Compare Blackrock Inc (BLK) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackrock Inc vs Charles River Laboratories Intl. Inc — how do they compare? Blackrock Inc trades at $1,148.43 (market cap $177.92B), while Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B). The key difference: Blackrock Inc is far larger — about 13.2× Charles River Laboratories Intl. Inc's market cap, and Blackrock Inc pays a 2% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| BLK | CRL | |
|---|---|---|
Market Cap | $177.92B | $13.46B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $282.00 |
52-Week Low | $922.90 | $145.57 |
Enterprise Value | $179.02B | $16.30B |
Dividend Yield | 2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BLK trades at $1,131.40, down slightly by 0.44% today, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $24.22 billion for 2025, with net income of $5.55 billion, and has consistently beaten EPS estimates in recent quarters. Recent news highlights BlackRock's involvement in a major AI financing initiative with Nvidia and other firms.
The outlook remains positive given strong earnings performance and a consensus buy rating from analysts, with a price target of $1,350. Key risks include potential legal challenges from investor lawsuits and volatile cash flow trends, but institutional confidence and strategic partnerships provide a solid foundation for growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackrock Inc
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →
